Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Cat . Non | Espèces | Description du produit | Structure | Pureté | Caractéristique |
---|---|---|---|---|---|
GMP-L21H25 | Human | GMP Human IL-21 Protein |
|
||
IL1-M52H3 | Mouse | Mouse IL-21 Protein, His Tag |
|
||
CRS-A010 | Human | resDetect™ Human Interleukin-21 (IL-21) ELISA Kit (Residue Testing) | |||
IL1-C52H9 | Cynomolgus | Cynomolgus IL-21 Protein, His Tag |
|
||
IL1-H5213 | Human | Human IL-21 Protein, premium grade |
|
||
IL1-H5253 | Human | Human IL-21 Protein, Fc Tag |
|
||
IL1-H82F7 | Human | Biotinylated Human IL-21 Protein, Fc,Avitag™, premium grade |
|
GMP Human IL-21 Protein (Cat. No. GMP-L21H25) stimulates secretion of IFN-γ by NK-92 human natural killer lymphoma cells stimulated with 10 ng/mL GMP Human IL-15 Protein (Cat. No. GMP-L15H13). The specific activity of GMP Human IL-21 Protein (Cat. No. GMP-L21H25) is > 1.00×10^5 U/mg (QC tested).
Human IL-21, premium grade (Cat. No. IL1-H5213) stimulates secretion of IFN-γ by NK-92 human natural killer lymphoma cells stimulated with 10 ng/mL Human IL-15, premium grade (Cat. No. IL5-H4117). The specific activity of Human IL-21, premium grade (Cat. No. IL1-H5213) is > 1.00×10^5 U/mg (QC tested).
Biotinylated Human IL-21, Fc,Avitag, premium grade (Cat. No. IL1-H82F7) immobilized on CM5 Chip can bind Human IL-21 R, Fc Tag (Cat. No. ILR-H5257) with an affinity constant of 0.165 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Avizakimab | BOS-161721 | Phase 2 Clinical | Medimmune, Boston Pharmaceuticals Inc | Lupus Erythematosus, Systemic | Details |
IL-21 mab (Lilly) | Phase 1 Clinical | Eli Lilly And Company | Immune System Diseases | Details | |
hV-01 | hV-01 | Phase 1 Clinical | Hangzhou Converd Co Ltd | Solid tumours | Details |
Avizakimab | BOS-161721 | Phase 2 Clinical | Medimmune, Boston Pharmaceuticals Inc | Lupus Erythematosus, Systemic | Details |
IL-21 mab (Lilly) | Phase 1 Clinical | Eli Lilly And Company | Immune System Diseases | Details | |
hV-01 | hV-01 | Phase 1 Clinical | Hangzhou Converd Co Ltd | Solid tumours | Details |
This web search service is supported by Google Inc.